However, to the best of our knowledge, we are one of the first studying the genomic alterations in the AR gene in BC in more detail and strikingly found that 88% of all patients displayed likely pathogenic and pathogenic (defined by guidelines of the association for molecular pathology [26]) AR variants. Here, AR is linked to breast cancer.